Last fall, Vice Chancellor for Research Roberto Peccei advised of an increase in the indirect cost rate for industry initiated and supported clinical trials to 26% (of total direct costs). Effective July 1, 2006, the same rate of 26% will be applied to Principal Investigator-initiated industry funded clinical trials. Thus the indirect cost rate for all industry supported clinical trials will be 26% (applied to total direct costs.)
Posted On